Țară: Australia
Limbă: engleză
Sursă: Department of Health (Therapeutic Goods Administration)
human menopausal gonadotrophin, Quantity: 600 IU
Ferring Pharmaceuticals Pty Ltd
Injection, solution
Excipient Ingredients: arginine hydrochloride; methionine; polysorbate 20; phenol; sodium hydroxide; dilute hydrochloric acid; water for injections
Subcutaneous
Pack of 1 pre-filled multidose pen and 12 needles
(S4) Prescription Only Medicine
MENOPUR is indicated for the treatment of infertility in the following clinical situations:,Anovulatory infertility, including polycystic ovarian disease (PCOD), in women who have been unresponsive to treatment with clomiphene citrate.,Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART) (e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)).
Visual Identification: MENOPUR solution for subcutaneous injection is clear solution free of visible particles, supplied in colourless cartridges fitted into pre-filled pen injection device.; Container Type: Cartridge; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Registered
2022-01-24